Evrys Bio
Evrys Bio

Evrys Bio Information

Contact top employees from Evrys Bio

Summary

Evrys Bio is a privately held biotech focused on Antivirals. We were founded on breakthrough discoveries from Princeton University. Whereas immuno-oncology drugs engage the patient’s immune system to...Show more

Organization Website

evrysbio.com

Social Links

linkedIn

Phone Number

609-874-9013

Industries

Headquarters Location

3805 Old Easton Road, Doylestown, PA, 18902 US

Employees Size

1-10 employees

Founded

2012

Competitors

Founded
Type
Employees
Revenue
Funding
2017Privately
Held
10-50 < 1M $3M
2011- 500-1000 - $-
2008- 500-1000 - $-

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Evrys Bio shows a diverse range of experience levels:
10% have been with the company for less than 1 year20% for 1–2 years20% for 3–4 years10% for 5–7 years10% for 8–10 years30% have over 11 years of service at Evrys Bio
Ex-employees positions
In Company
In New Company
Contact top employees from Evrys Bio

FAQ

Evrys Bio operates in the Pharma industries. More details can be found on the official website: evrysbio.com.
The headquarters of Evrys Bio are located in Doylestown, United States.
You can contact Evrys Bio by phone at 609-874-9013.
Evrys Bio currently employs 1-10 people.
Well-known competitors of Evrys Bio include Lucy Therapeutics, Aimmune Therapeutics and Apellis Pharmaceuticals.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP